Continuous Monitoring on the General Ward

Not Applicable

Completed

• Conditions: Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Arthritis; Hypertension; Sepsis
• Interventions: Device: HealthPatch; Device: ViSi Mobile

• Registration Number: NCT02933307
• Lead Sponsor: Radboud University Medical Center

Brief Summary

Rationale: Monitoring patients' vital signs is done to detect clinical deterioration. For this, the MEWS, a scoring list comprising seven vital signs measured by nursing staff, is used. Although the MEWS provides relevant data on patients' health status, the interval measurements may not capture early deterioration of vital signs, especially during the night. As a result, unsafe situations may occur such as periods of low oxygen saturation and cardiac arrhythmias, which are known to complicate postoperative course. Besides, this way of measuring vital signs may be stressful for patients and disturbs patients' sleep. New technology such as ViSi Mobile and HealthPatch allows for remote continuous monitoring of vital signs using wearable devices transmitting relevant data to nurses and clinicians. With this, the investigators think that clinical deterioration may be detected in an early phase and reduce nurse work load and patient distress.

Objective: to investigate the feasibility of wearable devices on the general ward.

Study design: feasibility study.

Study population: adult patients hospitalized on the internal medicine ward and adult postoperative patients on the surgical ward.

Intervention: patients in the intervention groups will be randomized in one of the two groups. Patients in the group 1 will wear ViSi Mobile; patients in group 2 will wear the HealthPatch. Wearable devices will be worn for at least three days. Regular MEWS measurements take place at usual time points.

Main study parameters/endpoints: Evaluation with patient and care givers (primary outcome measure), MEWS calculations, time between alarm (continuous data) and next regular MEWS measurement (nurse), intervention by nurse after alarm, admission to ICU, complications, side effects of devices, STAI scores, and PCS scores will be documented.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Patients will wear one device for at least three days. Devices can be uncomfortable by being heavy or the patches can start itching. More measurements by nurses can take place when indicated, for example after alarms. The participating patients will fill out the STAI on daily basis and the PCS on the last day of hospitalization. Both questionnaires will take a few minutes to complete. Patients could benefit from early detection of clinical deterioration and early corrective interventions or ICU admissions.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-04
• Status Verified: 2016-07
• Study First Submitted: 2016-07-25
• Primary Completion: 2016-08
• Study Completion: 2016-09
• Study First Submitted QC: 2016-10-13
• Study First Posted: 2016-10-14
• Last Update Submitted: 2017-04-24
• Last Update Posted: 2017-04-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Patient is 18 years or older on the day the informed consent will be signed.
• Patient is hospitalized on the surgical or internal medicine ward.
• MEWS measurements are required at least three times a day.
• Patient is able to speak, read and understand the local language of the investigational site, is familiar with the procedures of the study, and agrees to participate in the study program by giving oral and written informed consent prior to screening evaluations.

Read More

Exclusion Criteria

• Frequency of MEWS measurements is less than three times a day.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
HealthPatch (Intervention)	HealthPatch	Patients with HealthPatch and regular MEWS measurements
ViSi Mobile (Intervention)	ViSi Mobile	Patients with ViSi Mobile and regular MEWS measurements

Primary Outcome Measures

Name	Time	Method
Expectations & experiences of care givers	1 year	Interviews with nurses of 15-20 minutes at the end of the study. Estimated amount of 6 nurses
Expectations & experiences of patients	2-3 days after informed consent	Interviews of 15-20 minutes with patients after 2-3 days wearing a device or control group

Secondary Outcome Measures

Name	Time	Method
Time between alarm (continuous data) and next regular MEWS measurement (nurse)	during 2-3 days when the patient wears a device
Admission to ICU (yes/no)	during 2-3 days when the patient participates in this study
Technical failures of devices (artifacts: a period longer than 1 minute the device does not measure vital parameters)	during 2-3 days when the patient wears a device
Outcomes of the Pain Catastrophizing Scale (PCS)	On day 2 or 3 when patients participates in the study
Outcomes of the State Trait Anxiety Inventory (STAI)	Once a day during the 2-3 days the patient participantes in this study
MEWS scores based on continuous data and data measured by nurses	3 times a day, up to three days.
Amount of alarms by HealthPatch or ViSi Mobile	during 2-3 days when the patient wears a device
Amount of extra MEWS measurements by nurses due to alarms	during 2-3 days when the patient wears a device
Duration of ICU hospitalization in days	during 2-3 days when the patient participates in this study
Complications caused by disease or surgical procedure	during 2-3 days when the patient participates in this study
Adverse events caused by devices	during 2-3 days when the patient wears a device	E.g. Itch or redness
System usability Scale	1 year